Back
BioXcel Therapeutics Vs. Aldeyra Therapeutics Industry Stock Comparison
Sell
25
BTAI
BioXcel Therapeutics
Last Price:
2.71
Seasonality Move:
13.65%
Sell
27
ALDX
Aldeyra Therapeutics
Last Price:
3.95
Seasonality Move:
3.38%
Sell
25
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy, Sell or Hold?
- The current BioXcel Therapeutics [BTAI] share price is $2.71. The Score for BTAI is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- BTAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Aldeyra Therapeutics (ALDX)
is a Sell
Is Aldeyra Therapeutics a Buy, Sell or Hold?
- The current Aldeyra Therapeutics [ALDX] share price is $3.94. The Score for ALDX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- ALDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BTAI Stock Price Chart
What is BioXcel Therapeutics's stock price today?
-
The BioXcel Therapeutics share price today is $2.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
ALDX Stock Price Chart
What is Aldeyra Therapeutics's stock price today?
-
The Aldeyra Therapeutics share price today is $3.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALDX is experiencing slight buying pressure.
BTAI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 47.5 | Sell |
Chaikin Money Flow: | -613073 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.64 - 2.86) | Sell |
Bollinger Bands (100): | (2.61 - 3.37) | Sell |
ALDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 53.13 | Buy |
Chaikin Money Flow: | 22635 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.2 - 4.38) | Buy |
Bollinger Bands (100): | (2.97 - 3.87) | Buy |
BTAI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.73 | Sell |
20-day SMA: | 2.73 | Sell |
50-day SMA: | 2.9 | Sell |
200-day SMA: | 3.99 | Sell |
8-day EMA: | 2.76 | Sell |
20-day EMA: | 2.76 | Sell |
50-day EMA: | 2.87 | Sell |
200-day EMA: | 5.65 | Sell |
ALDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.96 | Sell |
20-day SMA: | 4 | Sell |
50-day SMA: | 3.62 | Buy |
200-day SMA: | 4.49 | Sell |
8-day EMA: | 3.97 | Sell |
20-day EMA: | 3.9 | Buy |
50-day EMA: | 3.68 | Buy |
200-day EMA: | 4.42 | Sell |
BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.29 per share.
Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and a decrease next year of $0.21 per share.
BioXcel Therapeutics Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aldeyra Therapeutics Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |